PROGRAMME - uhts.org.rs · Professor Aleksandar Lucic President DLTH Meeting 2009 Welcome Message....
Transcript of PROGRAMME - uhts.org.rs · Professor Aleksandar Lucic President DLTH Meeting 2009 Welcome Message....
PROG
RAM
ME
2
Organized by:
Serbian Society of Haemostasis and ThrombosisPresident: Danijela Mikovic Secretary General: Ljiljana Rakic
Danubian League against Thrombosis and Haemorrhagic DisordersPresident: Günter VogelSecretary General: Helmut Sinzinger
Blood Transfusion Institute of Serbia, Svetog Save 39, 11000 Belgrade • Phone: +381 11 2455 838 • Fax: +381 11 2458 328
Committees 4Welcome Message 5Programme Overview 7Scientifi c Programme - Oral Sessions 9Scientifi c Programme - Poster Session 19Map of the Meeting Rooms 28General Information 29Sponsoring and Exhibition 35
4 Danubian League against Thrombosis and Haemorrhagic Disorders
Committees
MEETING PRESIDENTAleksandar Lucic
ORGANIZING COMMITTEEDanijela Mikovic, PresidentVisnja CanakZoran StanojkovicVesna Subota
SCIENTIFIC COMMITTEEIvo Elezovic, PresidentHelmut SinzingerEmilija StojimirovicRadmila BaklajaPredrag MiljicNebojsa Antonijevic
SECRETARIATLjiljana RakicBiljana VuckovicGordana AntuljeskovDarko Antic
15th International Meeting, Belgrade 2009 5
Dear colleagues and friends,
On behalf of the Organizing Committee and on my own I wish a most cordial welcome to all participants of the 15th Danubian League Meeting against Thrombosis and Haemorrhagic Disorders, taking place from May 14 to 16, 2009 in Belgrade, capital of the Republic of Serbia.
By its primordial energy, the almighty Danube brings closer and unites people of various nationalities, religions, languages and cultural heritage. Almost thirty years ago Danube was the originator of the visionary professor Helmut Vinazzer’s idea of creating the Danubean League against Thrombosis and Haemorrhagic Disorders. Based on the Danubian affi liation, the Danubian League, in all its creative enthusiasm, gathers the experts of various medical and biological specialties, whose fundamental fi eld of interest resides within thrombosis and haemorrhagic syndromes.
It is our mutual wish to make the forthcoming meeting in Belgrade a strong stimulus for the improvement of traditional, professional and scientifi c regional cooperation.
Waiting for you openheartedly, wishing to make all three Belgrade Danubian League Meeting days memorable by the most up to date achievements in domain of haemostasis disorders research and by the friendly social activities, I address you once more with a most sincere and warm invitation to the next Danubian League Meeting in Belgrade, famous by its cordial hospitality.
Sincerely Yours,
Professor Aleksandar LucicPresident
DLTH Meeting 2009
Welcome Message
6 Danubian League against Thrombosis and Haemorrhagic Disorders
15th International Meeting, Belgrade 2009 7
Programme Overview
Thursday, May 14
14:30 – 16:30 Session: Venous Thromboembolism: Risk Factors, Diagnosis and Therapy
17:00 – 18:00 Satellite Symposium: Bayer Health Care, Bayer Schering Pharma
18:00 – 19:00 Satellite Symposium: Siemens Healthcare Diagnostics and Interlab exim
19:00 – 19:45 Opening Ceremony
20:00 – 22:00 Welcome Reception
Friday, May 15
08:30 – 09:00 Plenary Lecture
09:00 – 10:50 Session: Current and Future Assays of Haemostasis
11:10 – 11:40 Plenary Lecture
11:40 – 13:00 Session: Periodontal Disease and Haemostasis
Session: Pediatric Haemostasis
13:00 – 14:00 Satellite Symposium: Novo Nordisk
14:00 – 15:00 Lunch sponsored by Novo Nordisk
15:00 – 15:30 Plenary Lecture
15:00 – 16:50 Session: Principles of Haemophilia Care
16:50 – 17:15 Poster Session
17:15 – 17:30 Presentation: Instrumentation Laboratory
17:30 – 18:30 Satellite Symposium: Baxter
20:30 – 00:00 Gala Dinner sponsored by Baxter
Saturday, May 15
08:30 – 10:00 Visit to the Royal Palace
10:00 – 10:50 DLTH Assembly
10:50 – 11:40 Plenary Lecture
11:40 – 13:00 Session: Women and Haemostasis Disorders
Session: Arterial Thrombosis: Risk Factors and Therapy
13:00 – 14:00 Satellite Symposium: Octapharma
14:00 – 15:00 Lunch sponsored by Octapharma
15:00 – 15:30 Closing Ceremony
8 Danubian League against Thrombosis and Haemorrhagic Disorders
Scie
ntifi
c Pr
ogra
mm
e –
Oral
Ses
sion
s
10 Danubian League against Thrombosis and Haemorrhagic Disorders
Abbreviations:
PL - Plenary LectureSOA - State of the ArtOP - Oral PresentationPP - Poster Presentation
15th International Meeting, Belgrade 2009 11
Thursday, May 14, 2009 14:30-16:30 Room Atrium
VENOUS THROMBOEMBOLISM: RISK FACTORS, DIAGNOSIS AND THERAPYChairs: Alekandar Lucic, Sam Schulman, Ivo Elezovic
14:30 PL 1 THE OLD VERSUS THE NEW IN ANTICOAGULATION FOR VENOUS THROMBOEMBOLISMS. Schulman
15:00 SOA 2 OBSTACLES IN DIAGNOSTICS AND THERAPY OF HEPARIN-INDUCED THROMBOCYTOPENIAN. Antonijevic, N. Radovanovic, M. Kocica, D. Mikovic, M. Kovac, S. Tadic, I. Antonijevic, S. Draskovic, V. Djordjevic, B. Stojanovic, S. Obradovic, B. Calija, J. Perunicic, B. Terzic
15:20 OP 3 AN OVERVIEW OF GENETIC RISK FACTORS IN THROMBOPHILIAV. Djordjevic, Lj. Rakicevic, D. Radojkovic
15:30 OP 4 TAFI LEVELS AND Thr325Ile POLYMORPHISM INFLUENCE CLINICAL EXPRESSION OF THROMBOPHILIA IN CARRIERS OF FV LEIDEN OR FII 20210A MUTATIONS P. Miljic, E. Heylen, J. Willemse, V. Djordjevic, D. Radojkovic, M. Colovic, I. Elezovic, D. Hendriks
15:40 SOA 5 THROMBOSIS IN ANTIPHOSPHOLIPID SYNDROME: RESULTS FROM THE SERBIAN NATIONAL APS REGISTRYLj. Stojanovic, I. Elezovic, D. Marisavljevic, D. Petrovic, Z. Mikovic, R.Petrovic, R. Stojanovic, N. Damjanov, M. Mijailovic-Ivkovic, N. Milinic
16:00 OP 6 DIFFERENT D-DIMER TESTS COMPARING TO ULTRASOUND EXAMINATION OF DEEP VEIN THROMBOSIS D. Vasic, L. Davidovic, V. Dopsaj, M. Vranes, O. Radmili
16:10 OP 7 VALUE OF TRANSTHORACIC ECHOCARDIOGRAPHY IN THE DIAGNOSIS OF PULMONARY EMBOLISMD. Obradovic, U. Batranovic, B. Sevic, B. Zaric, J. Vucicevic-Trobok, B. Bogdanov
16:20 Discussion
16:30 - 17:00 Coffee break Business Centre
Thursday, May 14, 2009 17:00-19:45 Room Atrium
Thursday, May 14, 2009 20:00-22:00 Business Centre
17:00 Satellite Symposium Bayer Health Care, Bayer Schering Pharma
18:00 Satellite Symposium Siemens Healthcare Diagnostics and Interlab exim
19:00 Opening Ceremony
Welcome Reception
12 Danubian League against Thrombosis and Haemorrhagic Disorders
Friday, May 15, 2009 08:30-10:50 Room Atrium
CURRENT AND FUTURE ASSAYS OF HAEMOSTASISChairs: Igor Bokarev, Mojca Stegnar, Jovan Antovic
08:30 PL 32 HOW TO USE DIC DIAGNOSIS TODAY?I. N. Bokarev, L.V. Popova
09:00 SOA 33 FACTORS INFLUENCING FIBRIN STRUCTURE AND FUNCTION. RELEVANCE TO CLINICAL DISEASE A. Antovic, N.H. Wallen, F. Mobarrez, G. Jorneskog, S. He, M. Blomback
09:20 OP 34 THE ROLE OF ROTEM IN REAL TIME ASSESSMENT OF HEMOSTASIS IN SURGICAL SETTINGSD. Vucelic, P. Miljic
09:30 OP 35 ESTIMATION OF THROMBIN PRODUCTION IN DIFFERENT SUBJECTSM.P. Makris, P.E. Makris
09:40 SOA 36 HOW TO MEASURE PLATELET MICROPARTICLES USING FLOW-CYTOMETRY? F. Mobarrez, N. H. Wallen, N. Egberg, G. Jorneskog , M. Hansson, J. Antovic
10:00 OP 37 FLOW CYTOMETRIC AND FUNCTIONAL INVESTIGATIONS OF CRYOPRESERVED AND LIQUID STORED PLATELETSD. Vucetic, B. Balint, D. Vojvodic, S. Mandic-Radic, V. Subota, M. Trkuljic
10:10 SOA 38 PLATELET FUNCTION TESTS AND RESISTANCE TO ANTIPLATELET THERAPYM. Stegnar
10:30 OP 39 STUDY OF THE RESISTANCE TO ASPIRIN BY DETERMINATION OF GLYCOPROTEIN ON THE PLATELET MEMBRANEM. Moshou, M.P. Makris, G. Koliakos, P.E. Makris
10:40 Discussion
10:50-11:10 Coffee break Business Centre
15th International Meeting, Belgrade 2009 13
Friday, May 15, 2009 11:10-12:50 Room Atrium
PERIODONTAL DISEASE AND HAEMOSTASIS Chairs: Helmut Sinzinger, Andreas Eder, Milan Jurisic
11:10 PL 49 IS LIPOPROTEIN (a) REGULATING THE PROSTAGLANDIN I2-SYNTHESIS STIMULATING PLASMA FACTOR?H. Sinzinger, E. Ruppert, H. Laimer
11:40 OP 50 EFFECTS OF ENAMEL MATRIX DERIVATIVE (EMD) ON PROLIFERATION, MIGRATION AND ANGIOGENIC FACTOR EXPRESSION OF ENDOTHELIAL CELLS IN VITROK. Bertl, N. An, C. Bruckmann, M. Dard, O. Andrukhov, M. Matejka, X. Rausch-Fan
11:50 OP 51 INFLUENCE OF PERIODONTAL DISEASE ON CARDIOVASCULAR DISEASE PARAMETERSA. Eder, D.I. Ancutici
12:00 OP 52 (ISO-)EICOSANOID PRODUCTION PROFILE IN PERIAPICAL GRANULOMAS AND THEIR ROLE IN BONE DESTRUCTIONE. Kögl, A. Eder, H. Sinzinger
12:10 OP 53 (ISO-)PROSTANES - A MARKER FOR PARODONTOPATHY?C. Presenhuber, A. Eder, A. Nell, H. Sinzinger
12:20 OP 54 PLASMA BUT NOT SERUM THROMBOXANE B2 IS CORRELATED TO PERIODONTAL DISEASE INDICESH. Sinzinger, S. Marchesi, G. Lupattelli, A. Eder
12:30 OP 55 EFFECTS OF PORPHYROMONAS GINGIVALIS LIPOPOLYSACCHARIDE ON HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS WITH REGARD TO EXPRESSION OF CELL ADHESION MOLECULESI. Steiner, O. Andrukhov, S. Liu, M. Matejka, X. Rausch-Fan
12:40 Discussion
14 Danubian League against Thrombosis and Haemorrhagic Disorders
Friday, May 15, 2009 11:50-13:00 Room Beograd
Friday, May 15, 2009 13:00-14:00 Room Atrium
PEDIATRIC HAEMOSTASIS Chairs: Emilija Stojimirovic, Nada Rasovic, Dejan Skoric
11:50 OP 56 TREATMENT OF INTRACRANIAL HAEMORRHAGE WITH RECOMBINANT FACTOR VIIa IN A PATIENT WITH APLASTIC ANEMIAD. Janic, N. Krstovski, L. Dokmanovic, P. Rodic
12:00 OP 57 KASABACH-MERRITT SYNDROME - ASSOCIATED KAPOSIFORM HEMANGIOENDOTHELIOMA: SUCCESSFULLY TREATED VASCULAR NEOPLASMA WITH CONSUMPTIVE COAGULOPATHYD. Aleksic, D. Djokic, R. Simic, S. Djuricic, D. Redzic, M. Jovic, A. Sarajlija
12:10 OP 58 KASABACH-MERITT SYNDROME: A STATE OF ALARMING CONSUMPTIVE COAGULOPATHY S. Sindjic-Antunovic, D. Skoric, M. Jesic, M. Lukac, D. Vujovic, Z. Krstic, S. Maglajlic
12:20 OP 59 COAGULATION DISTURBANCES IN PATIENTS WITH VENO-OCCLUSIVE DISEASE AFTER BONE MARROW TRANSPLANTATIOND. Jevtic, D. Vujic, Z. Zecevic, D. Veljkovic, S. Gazikalovic
12:30 OP 60 IMPORTANCE OF LIFELONG ORAL ANTICOAGULANT THERAPY IN ADOLESCENT WITH CONGENITAL THROMBOPHILLIAM. Jovic, D. Redzic, O. Serbic, D. Aleksic, D. Djokic
12:40 OP 61 INFLUENCE OF OBSTETRIC FACTORS ON QUALITY OF UMBILICAL CORD BLOOD UNITSD. Skoric, M. Sindjic, M. Saracevic
12:50 Discussion
Satellite Symposium Novo Nordisk
14:00-15:00 Lunch sponsored by Novo Nordisk Restaurant Exclusive
15th International Meeting, Belgrade 2009 15
Friday, May 15, 2009 15:00-16:50 Room Atrium
Friday, May 15, 2009 16:50-17:15 Room Forum
Friday, May 15, 2009 17:15-17:30 Room Atrium
Friday, May 15, 2009 17:30-18:30 Room Atrium
Friday, May 15, 2009 20:30 Kalemegdanska terasa
PRINCIPLES OF HAEMOPHILIA CARE Chairs: Christopher Ludlam, Danijela Mikovic, Radmila Baklaja
15:00 PL 69 HAEMOPHILIA CARE IN EUROPE – HOW CAN WE IMPROVE IT?C. Ludlam
15:30 OP 70 BUILDING THE REGISTRIES AND NETWORKS FOR HEMOPHILIA CARE. A NATIONAL APPROACH: SLOVAKIAA. Batorova, M. Zarnovicanova
15:40 OP 71 QUALITY OF HEMOPHILIA TREATMENT IN SERBIA: NATIONAL HAEMOPHILIA REGISTRY REPORTD. Mikovic, Lj. Rakic, G. Jankovic-Trsnjak, R. Baklaja
15:50 OP 72 CONTINUOUS FVIII REPLACEMENT FOR OPEN HEART SURGERY IN THE NEWBORN - A CASE REPORTM. Kuzmanovic, M. Stajevic, V. Vukomanovic, N. Rasovic, B. Jankovic,O. Serbic
16:00 OP 73 MOLECULAR GENETIC DIAGNOSTICS OF HEMOPHILIA A IN SLOVENE PATIENTSM. Debeljak, L. Kitanovski, M. Benedik-Dolnicar
16:10 OP 74 PROPHYLAXIS IN ADULTS WITH HAEMOPHILIA A: BENEFIT OR RISK?S. Zupancic-Salek
16:20 OP 76 ORTHOPAEDIC MANAGEMENT OF MUSCULOSCELETAL COMPLICATIONS OF HAEMOPHILIA PATIENTS IN HUNGARYL. Nemes, L. Bartha
16:30 OP 77 BENEFITS OF EARLY TREATMENT OF BLEEDINGIN HAEMOPHILIA PATIENTS WITH INHIBITORSP. Salaj
16:40 Discussion
Poster Session & Coffee Break
Presentation Instrumentation Laboratory
Satellite Symposium Baxter
Gala Dinner sponsored by Baxter
16 Danubian League against Thrombosis and Haemorrhagic Disorders
Saturday, May 16, 2009
Saturday, May 16, 2009 10:50-12:20 Room Atrium
08:30-10:00 Visit to the Royal Palace
10:00-10:50 DLTH Assembly Room Beograd
10:30-10:50 Coffee break Business Centre
WOMEN AND HAEMOSTASIS DISORDERS Chairs: Flora Peyvandi, Gorana Mitic, Predrag Miljic
10:50 PL 92 OBSTETRIC AND GYNECOLOGICAL PROBLEMS IN WOMEN WITH INHERITED BLEEDING DISORDERSF. Peyvandi
11:20 OP 93 MENORRHAGIA AND COAGULATION ABNORMALITIESS. Djukic, N. Andjelkovic, P. Djurdjevic, A. Djukic, J. Antovic
11:30 OP 94 EFFICACY AND SAFETY OF THE LOW MOLECULAR WEIGHT HEPARIN NADROPARIN AND UNFRACTIONATED HEPARIN FOR TREATMENT OF VENOUS THROMBOEMBOLISM DURING PREGNANCY AND PUERPERIUM G. Mitic, M. Kovac, Lj. Povazan, V. Djordjevic, Z. Magic, I. Salatic, R. Lazic, N. Antonijevic, A. Novakov-Mikic
11:40 OP 95 RECURRENT FETAL LOSSES: ETIOLOGICAL AND THERAPEUTIC APPROACH USING MAINLY THE INNOHEPA. Foifa, M.P. Makris, A. Kanidis, P.E. Makris
11:50 OP 96 CORRELATION BETWEEN THE LOW MOLECULAR WEIGHT HEPARIN DOSE AND THE PLASMA LEVELS OF ANTI Xa ACTIVITY IN PREGNANT WOMENM. Scekic, G. Mitic, Dj. Jurisic, Lj. Povazan, R. Tesic, M. Petkovic, B. Jakovljevic, Z. D. Jelicic
12:00 Discussion
15th International Meeting, Belgrade 2009 17
Saturday, May 16, 2009 11:20-13:00 Room Beograd
Saturday, May 16, 2009 13:00-14:00 Room Atrium
Saturday, May 16, 2009 15:00-15:30 Room Atrium
ARTERIAL THROMBOSIS: RISK FACTORS AND THERAPYChairs: Günter Vogel, Graziana Lupattelli, Rajko Radovancevic
11:20 SOA 97 LIPOPROTEINS AND ATHEROGENESIS: AN UPDATE G. Lupattelli
11:40 OP 98 FIBRINOLYTIC DISORDERS AND Lp(a) LIPOPROTEIN IN ISCHEMIC STROKE PATIENTS B. Vuckovic, V. Canak, M. Djeric, S. Novaković-Anucin, S. Gnip, T. Ilic
11:50 SOA 99 THROMBOGENIC PROFILE OF LEUKOCYTES: CLINICAL AND EXPERIMENTAL EVIDENCESN. Maugeri
12:10 OP 100 EFFECT OF, UMBILICAL CORD, BLOOD CELLS IN THE “EXPRESSION” OF PLATELET GLYCOPROTEIN RECEPTORSM. Moshou, D. Vasileiadou, M.P. Makris, G. Koliakos, P.E. Makris
12:20 OP 101 EXTREMELY HIGH LEVELS OF PLATELET ACTIVATION MARKERS ASSOCIATED WITH CEREBROVASCULAR ACCIDENTR. Radovancevic, N. Matijevic, A. Bracey, I. Gregoric, O.H. Frazier
12:30 OP 102 HAEMOSTASIS PARAMETERS FOR THE PREDICTION OF ISCHEMIA DURING ADENOSINE-EXERCISE-SPECT STRESS TEST IN ASYMPTOMATIC CORONARY PATIENTS AFTER CORONARY STENTINGS. Obradovic, B. Baskot, V. Subota, D. Mikovic, N. Antonijevic, J. Antovic, N. Djenic, B. Gligic
12:40 OP 103 THE EFFECT OF THE ANTIAGGREGATIONAL THERAPY ON THE BYPASS LONG-TERM PATENCYD. Vasic, L. Davidovic, Z. Maksimovic, O. Radmili, M. Vranes
12:50 Discussion
Satellite Symposium Octapharma
14:00-15:00 Lunch sponsored by Octapharma Restaurant Exclusive
Closing Ceremony
18 Danubian League against Thrombosis and Haemorrhagic Disorders
Scie
ntifi
c Pr
ogra
mm
e –
Post
er S
essi
on
20 Danubian League against Thrombosis and Haemorrhagic Disorders
15th International Meeting, Belgrade 2009 21
VENOUS THROMBOEMBOLISM: RISK FACTORS, DIAGNOSIS AND THERAPY
POSTER PRESENTATIONS
PP 8 NATIONAL REGISTRY OF THROMBOPHILIC STATES IN SLOVAK REPUBLICI. Plamenova, J. Chudej, K. Gregorova, L. Bartosova, M. Dobrotova, P. Chudy, J. Stasko, P. Kubisz
PP 9 PREVALENCE OF THROMBOPHILIC DEFECTS IN WOMEN WITH VENOUS THROMBOEMBOLISM IN PREGNANCY AND PUERPERIUM AND ITS CONNECTION WITH THROMBOSIS LOCALIZATION G. Mitic, M. Kovac, Lj. Povazan, V. Djordjevic, Z. Magic, I. Salatic, R. Lazic, N. Antonijevic, A. Novakov-Mikic
PP 10 HOMOCYSTEINEMIA LEVELS AND METHYLENTETRAHYDROFOLATE REDUCTASE C677T GENOTYPES IN PATIENTS WITH PULMONARY EMBOLISMN. Antonijevic, A.Beletic, D. Mirkovic, V. Sango, I. Novakovic, V. Djordjevic, S. Obradovic, J. Perunicic, G.Mitic, B. Jakovljevic, Z. Vasiljevic
PP 11 REVIEW OF PATIENT WITH THROMBOPHILIA ASSOCIATED WITH ESSENTIAL THROMBOCYTHAEMIAN. Govedarovic, D. Markovic, T. Vukicevic, M. Vucic
PP 12 MESO-ATRIAL SHUNT FOR MANAGEMENT OF FACTOR V LEIDEN RELATED BUDD-CHIARRI SYNDROME: CASE REPORTM. Veljovic, A. Popadic
PP 13 RECURRENT DEEP VENOUS THROMBOSES IN A PATIENT WITH FACTOR V LEIDEN AND MTHFR C677T MUTATIONS B. Teodorovic, Dj. Teodorovic, D. Kokar-Gusa, S. Martinovic-Poljak
PP 14 CONGENITAL-CYANOTIC HEART DISEASE AND HYPERCOAGULABILITY OF BLOOD - CASE REPORTO. Simonovic, L. Macukanovic-Golubovic, T. Vukicevic, D. Tasic
PP 15 POSTOPERATIVE DEEP VEIN THROMBOSIS AFTER LAPAROSCOPIC CHOLECYSTECTOMYZ. Stanojkovic, D. Milic
PP 16 THROMBOSIS OF THE INFERIOR VENA CAVA AND PULMONARY THROMBOEMBOLISMJ. Vucicevic-Trobok, B. Bogdanovic, S. Pekovic, M. Stojanovic, O. Obradovic
PP 17 PULMONARY EMBOLISM IN INTENSIVE CARE UNITN. Bogdanovic, M. Bojic, V. Celic, M. Dekleva, Dj. Lalosevic
PP 18 CORRELATION BETWEEN PAI-1 AND Lp(a) IN DEEP VENOUS THROMBOSISE. Todorovska, T. Makarovska-Bojadjieva, S. Kostovska
PP 19 FIBRINOLYSIS DISTURBANCE IN DEEP VENOUS THROMBOSISE. Todorovska, T. Makarovska-Bojadjieva, N. Dimoska
22 Danubian League against Thrombosis and Haemorrhagic Disorders
POSTER PRESENTATIONS
PP 20 THE USE OF D-DIMER WITH NEW THRESHOLD CAN BE USEFUL IN DIAGNOSIS OF VENOUS THROMBOEMBOLISM IN PREGNANCYM. Kovac, Z. Mikovic, Lj. Rakicevic, S. Srzentic, V. Mandic, O. Savic, V. Djordjevic, D. Radojkovic, I. Elezovic
PP 21 THE MANAGEMENT OF VENOUS THROMBOEMBOLISMI. Nikoloska, R. Apostolovska, V. Neceva, J. Angelovski, E. Velkova, T. Makarovska, D. Stambolieva, S. Atanasova
PP 22 THE USE OF THROMBOPROPHYLAXIS IN THE PATIENS WITH GENERAL AND GYNECOLOGIC SURGERYK. Lazarovski, V. Karamandi-Lazarovska, E. Todorovska, R. Dukovski
PP 23 ANTITHROMBOTIC THERAPY IN PATIENTS WITH MECHANICAL HEART VALVESV. Canak, Lj. Povazan, G. Mitic, S. Novakovic-Anucin, S. Gnip, B. Vuckovic, P. Filipov, M. Scekic
PP 24 ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION IN MACEDONIAR. Apostolovska, K. Dimitrovski, V. Dejanova, T. Balkanov, V. Neceva, S. Useini, I. Nikoloska
PP 25 HEMORRHAGIC AND THROMBOEMBOLIC COMPLICATIONS DURING ANTITHROMBOTIC PREVENTIVE THERAPY IN ATRIAL FIBRILLATIONS. Gnip, S. Novakovic-Anučin, V. Canak, Lj. Povazan, G. Mitic, B. Vuckovic, P. Filipov, M. Scekic
PP 26 FOLLOW UP OF ORAL ANTICOAGULANT THERAPYM. Paunovic, Lj. Suput-Tomas, B. Janković-Orescanin
PP 27 FOLLOW UP OF THE ORAL ANTICOAGULANT THERAPY – OUR EXPERIENCE Lj. Ilincic, B. Mihic-Tomic, S. Stojkovic, M. Bozovic, V. Djurovic
PP 28 HOW TO USE GENETIC INFORMATION DURING THE TREATMENT OF PATIENTS WITH ANTIVITAMINS KT. Kondratieva, I. N. Bokarev
PP 29 EFFICACY AND SAFETY OF UNFRACTIONATED AND LOW MOLECULAR WEIGHT HEPARIN USED AS PERIOPERATIVE BRIDGING THERAPY IN PATIENTS WITH MECHANICAL HEART VALVES G. Mitic, Lj. Povazan, S. Gnip, S. Novakovic-Anucin, M. Scekic
PP 30 BLEEDING CONTROL AFTER TEETH EXTRACTIONS IN PATIENTS ON ORAL ANTICOAGULANT TREATMENT WITHOUT THERAPY INTERRUPTIOND. Stojanovic, S. Colic, E. Krsljak, M. Jurisic
PP 31 HEPARIN-INDUCED THROMBOCYTOPENIA OCCURRED AFTER CARDIOSURGICAL TREATMENT OF ATRIAL MIXOMA: A CASE REPORTI. Djunic, D. Tomin, N. Antonijevic, M. Kovac, G. Jankovic, A. Vidovic, I. Elezovic
15th International Meeting, Belgrade 2009 23
CURRENT AND FUTURE ASSAYS OF HAEMOSTASIS
POSTER PRESENTATIONS
PP 40 COMPARISON OF THREE METHODS FOR D-DIMER DETERMINATIONS. Jurkic, M. Perovic
PP 41 D-DIMER TEST APPLICATION IN THE HEALTH CARE CENTRE OF SOMBORE. Adjic-Tosegi
PP 42 HAEMOSTASIS SCREENING TESTS IN POTENTIAL PLATELET APHERESIS DONORS N. Vavic, D. Mikovic, Lj. Rakic, M. Sindjic, S. Draskovic, M. Kovac, A. Maslac, Z. Garic, V. Srejic
PP 43 MULTIPLATE®- BASED POINT-OF-CARE MANAGEMENT FOR DIAGNOSIS AND TREATMENT OF BLEEDING DURING HEART SURGERYB. Calija, M. Jovic, B. Djukanovic
PP 44 QUALITY CONTROL - DETERMINATION OF LOCALLY OWN REFERENCE RANGES USING MULTIPLATE®V. Libek, A. Kulic, A. Strugar, L. Mijovic-Nikolic, N. Rankovic
PP 45 STICKY PLATELET SYNDROME: ROLE OF FLOW CYTOMETRYP. Kubisz, L. Bartosova, J. Fedorova, J. Ivankova, P. Holly, J. Stasko
PP 46 PLATELET FUNCTION AND COAGULATION ABNORMALITIES IN TYPE 1 GAUCHER PATIENTM. Mitrovic-Vasiljevic, N. Suvajdzic, I. Elezovic, P. Miljic, Z. Sumarac, D. Janic, M. Djordjevic, M. Petakov, I. Djunić, P. Rodic
PP 47 THE USEFULNESS OF PFA-100 CLOSURE TIME AS SCREENING TEST FOR VON WILLEBRAND DISEASEL. Kitanovski, V. Rajic, A. Trampus, M. Benedik-Dolnicar
PP 48 IMPLEMENTATION OF THE SEMIQUANTITATIVE ANALYSIS OF VON WILLEBRAND FACTOR MULTIMERS USING SDS AGAROSE ELECTROPHORESIS METHODI. Jaglicic, O. Savic, D. Mikovic, M. Jovicic
PEDIATRIC HAEMOSTASIS
PP 62 LUPUS ANTICOAGULANT ANTIBODIES IN CHILDRENO. Serbic, M. Djuric, G. Vlahovic, D. Veljkovic, M. Kuzmanovic, D. Micic, S. Pasic, D. Jevtic
PP 63 HYPERCOAGULABILITY IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIAV. Bogicevic, G. Kostic, D. Jovancic, A. Kostic
24 Danubian League against Thrombosis and Haemorrhagic Disorders
POSTER PRESENTATIONS
PP 64 THROMBOTIC MICROANGIOPATHY INDUCED BY CMV AND HHV6 INFECTION AFTER ALLOGENEIC BONE MARROW TRANSPLANTATIONZ. Zecevic, D. Vujic, D. Jevtic, D. Veljkovic, O. Serbic
PP 65 COAGULATION TESTING OF NEWBORN WITH CEPHALHEMATOMAV. Libek , A. Kulic, L. Mijovic-Nikolic, A. Strugar, N. Rankovic, B. Kovacevic
PP 66 VITAMIN K DEFICIENCY BLEEDING IN A CHILD WITH CHOLESTASISN. Krstovski, S. Radulovic, D. Janic, L. Dokmanovic, P. Rodic, Z. Krstic
PP 67 CHARACTERISTICS AND MANAGEMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOODK. Martinova, O. Muratovska, S. Glamocanin, Z. Antevska-Trajkova, B. Conevska, S. Koceva
PP 68 SAFETY OF LUMBAR PUNCTURE IN THROMBOCYTOPENIA - PROPHYLACTIC PLATELET TRANSFUSIONS BEFORE LUMBAR PUNCTURE; YES OR NO L. Kitanovski, A. Trampus-Bakija, M. Benedik-Dolnicar
PRINCIPLES OF HAEMOPHILIA CARE
PP 78 IS THERE AN IMPROVEMENT IN THE HEMOPHILIA CARE IN MACEDONIA?S. Stankovic, T. Smilevska, T. Sotirovska, S. Trajkova, A. Ljatifi
PP 79 SOME CHARACTERISTICS OF PATIENTS WITH HEMOPHILIA IN REPUBLIC OF SRPSKA - BOSNIA AND HERZEGOVINAJ. Predojevic-Samardzic, B. Djurdjevic-Banjac, D. Malcic-Zanic
PP 80 MULTICENTRIC EVALUATION OF HEALTH-RELATED QUALITY OF LIFE IN ROMANIAN HAEMOPHILIACS M. Serban, M.D.Mihailov, L. Pop, A. Lacatusu, L. Rittli, P. Stancu, A. Cucuianu, E. Ursu
PP 81 GENETIC DIAGNOSIS OF HAEMOPHILIA AND PRENATAL DIAGNOSIS. SLOVENIAN EXPIERENCESM. Benedik-Dolnicar, L. Kitanovski, M. Debeljak
PP 82 HEMOREC - A CLINICAL REGISTRY FOR HAEMOPHILIA PATIENTSP. Brabec, T. Pavlík, P. Salaj
PP 83 SUCCESFULL TREATMENT OF HUGE ILIOPSOAS HEMATHOMA IN PATIENT WITH MILD HEMOPHILIA AM. Vucic, T. Vukicevic, N. Govedarovic, L. Macukanovic-Golubovic
PP 84 ILIOPSOAS BLEEDING IN CHILDHOOD HAEMOPHILIA - SINGLE CENTER EXPERIENCEP. Rodic, L. Dokmanovic, N. Krstovski, J. Lazic, Z. Smoljanic, D. Janic
15th International Meeting, Belgrade 2009 25
POSTER PRESENTATIONS
PP 85 ORTHOPEDIC STATUS OF HEMOPHILIACS IN ROMANIA – A MULTICENTRIC STUDYL. Pop, L. Rittli, P. Stancu, A. Cucuianu, D. Mihailov, A. Lacatusu, E. Ursu, L. Barna, W. Schramm, M. Serban
PP 86 HIP SURGERY IN A HEMOPHILIC PATIENTS. Stankovic, A. Stojanovic, T. Smilevska, Z. Stojanovski, T. Sotirova, S. Trajkova, M. Lozance, A. Latifi , D. Dukovski, L. Cevreska
PP 87 INHIBITORS IN HEMOPHILIA PATIENTS IN UKRAINEO. Stasyshyn, V. Krasivska, V. Novak
PP 88 SUCCESSFUL TREATMENT OF INTRACRANIAL HAEMORRHAGE AND COMPARTMENT SYNDROME OF THE NECK IN PATIENT WITH HAEMOPHILIA A AND INHIBITORSD. Antic, I. Elezovic, P. Miljic, L. Davidovic, P. Djoric
PP 89 RECOMBINANT FACTOR VIIa IN TREATMENT OF NONTRAUMATIC SPONTANEOUS INTRAMURAL SMALL-BOWEL HAEMATHOMA IN HAEMOPHILIA A PATIENT - CASE REPORTI. Savic, I. Percic, N. Rajic, S. Popovic, B. Pilipovic
PP 90 RECOMBINANT FACTOR VIIa FOR TREATMENT OF ACQUIRED HAEMOPHILIA - CASE REPORT D. Markovic, T. Vukicevic, E. Miljkovic, M. Pavlovic
PP 91 THE EFFECTIVENESS OF DDAVP IN PREVENTING OF BLEEDING IN PATIENTS WITH VON WILLEBRAND DISEASE UNDERWENT ORAL SURGERY PROCEDURESM. Gardasevic, S. Colic, M. Jurisic, V. Jurisic
ARTERIAL THROMBOSIS: RISK FACTORS AND THERAPY
PP 104 RELATIONSHIP OF ALCOHOL CONSUMPTION AND THROMBOGENIC FACTORS IN HYPERTENSIVE MALESG. Vyssoulis, E. Karpanou, V. Tzamou, G. Theodosiadis, D. Adamopoulos, G. Antonakoudis, D. Cokkinos, C. Stefanadis
PP 105 FIBRINOGEN OF LOW MOLECULAR WEIGHT AND ITS ROLE IN ATHEROGENESIS AT PATIENTS WITH DIABETES MELLITUS 2nd TYPEA. Doronina, V. Lipinski, I.N. Bokarev
PP 106 THE COMPLEX’S ACTIVITY “VON WILLEBRAND FACTOR – GLYCO-PROTEIN IIb/IIIa” AT THE PATIENTS WITH ATHEROTHROMBOSIS OF THE HEART (CORONARY ARTERY DISEASE) AND PERIPHERAL ARTERIES (PERIPHERAL ARTERY DISEASE) PROGRESSING ON BACKGROUND OF DIABETES MELLITUS TYPE 2I. Smirnova
26 Danubian League against Thrombosis and Haemorrhagic Disorders
POSTER PRESENTATIONS
PP 107 ANTIOXIDATIVE PROPERTIES OF MOMORDICA CHARANTIA ON OXIDATION OF NATIVE AND MODIFIED LDLG. Sobal, W. Lehner, G. Stubiger, H. Sinzinger
PP 108 ANTI BETA 2 GLYCOPROTEIN I ANTIBODIES AT PATIENTS WITH DVT, CVI AND AMIV. Neceva, S. Kostovska, R. Apostolovska
PP 109 ELEVATIONS IN SOLUBLE CD40 LIGAND IN PATIENTS WITH HIGH PLATELET AGGREGABILITY UNDERGOING PCIS. Obradovic, J. Antovic, N. Antonijevic, V. Subota, D. Vojvodic, B. Gligic, J. Marinkovic, D. Obradovic, H. Wallen
PP 110 INTRAVENOUS TISSUE-TYPE PLASMINOGEN ACTIVATOR THERAPY FOR ISCHAEMIC STROKE: NIS STROKE TEAM EXPERIENCE N. Vukasinovic, S. Jolic, M. Zivkovic, M. Cvejic
FREE PAPERS
PP 111 DISSEMINATED INTRAVASCULAR COAGULATION AT AN EARLY PHASE OF TRAUMAA. Sawamura, S. Gando, M. Hayakawa, H. Hoshino, N. Kubota, N. Henzan, M. Sugano, T. Wada, K. Katabami
PP 112 HAEMOSTATIC DISORDERS IN PATIENTS WITH MASSIVE TRANSFUSIONT. Makarovska-Bojadzieva, S. Kostovska, E. Todorovska, M. Blagoevska,O. Damevska-Todorovska, E. Velkova, J. Angelovski, I. Nikoloska
PP 113 ANTIPHOSPHOLIPID SYNDROME AND HELICOBACTER PYLORY INFECTION - CASE REPORT O. Simonovic, L. Macukanovic-Golubovic, T. Vukicevic, D. Tasic
PP 114 THE MOST COMMON COAGULATION DISORDERS IN PATENTS WITH SOLID TUMORS - OUR EXPERIENCESLj. Tomasic, V. Vukov, A. Babic, B. Savic, V. Libek, A. Kulic, L. Mijovic, N. Rankovic
PP 115 USE OF PLATELETS IN PATIENTS WITH MALIGNANT DISEASESA. Antic, Z. Stanojkovic
PP 116 DEVELOPMENT OF THE DISEASE AND FATAL OUTCOME IN A PATIENT WITH BERNARD-SOULIER SYNDROMES. Stankovic, L. Cevreska, T. Smilevska, T. Sotirovska, S. Trajkova, L. Hadzi-Pecova, A. Ljatifi , D. Dukovski
PP 117 THE TREATMENT OF CRITICAL BLEEDING EPISODES IN PATIENTS WITH SERIOUS HAEMATOLOGICAL DISORDERS WITH RECOMBINANT FACTOR VIIa N. Rajic, A. Savic, .S. Popovic, I. Savic, I. Urosevic, D. Agic, B. Zeravica,N. Vlaisavljevic, I. Percic, D. Pejin
15th International Meeting, Belgrade 2009 27
POSTER PRESENTATIONS
PP 118 DIFFUSE CAVERNOUS HEMANGIOMA OF THE LEFT LEG, VULVA ET UTERUS IN A PREGNANT WOMAN: REPORT OF A RARE CASEI. Djunic, I. Elezovic, O. Markovic, J. Tadic, D. Tomin, D. Antic, A. Vidovic, A. Ljubic
PP 119 BIOLOGICAL EVALUATION OF SYNTHETIC LINEAR ANALOGUE PEPTIDES OF 1811-1818 LOOP OF THE A3 SUBUNIT OF THE LIGHT CHAIN A3-C1-C2 OF FVIII BLOOD COAGULATIONK. Patsialas, C.H. Koutsas, P.E. Makris, M. Liakopoulou–Kyriakides
PP 120 THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR IN PATIENTS WITH DIABETES MELLITUS TYPE 2 J. Stasko, P. Chudy, P. Holly, P. Galajda, I. Plamenova, P. Kubisz
PP 121 RADIONUCLIDE THERAPY WITH 153-SAMARIUM-EDTMP TEMPORARILY DECREASES PLATELET COUNT PARALLELEDBY AN INCREASED CELLULAR THROMBOXANE FORMATION E. Trifi na, A. Oguogho, J. Hiltunen, H. Sinzinger
PP 122 PLATELET LABELLING EFFICIENCY IS INFLUENCED NOT ONLY BY QUANTITATIVE BUT ALSO QUALITATIVE LIPOPROTEIN COMPOSITION F. Hajos, S. Granegger, B. Palumbo, R. Palumbo, H. Sinzinger
PP 123 IMPACT OF VALPROATS ON THE PLATELET NUMBER AND FUNCTIONZ. Igrutinovic, S. Obradovic, B. Vuletic, S. Markovic, A. Vujic, Z. Raskovic
PP 124 HAEMOVIGILANCE AND PHARMACOVIGILANCE IN MEDICATION OBTAINED FROM HUMAN PLASMAM. Romic
28 Danubian League against Thrombosis and Haemorrhagic Disorders
Gene
ral I
nfor
mat
ion
30 Danubian League against Thrombosis and Haemorrhagic Disorders
15th International Meeting, Belgrade 2009 31
“I have found a most beautiful, ancient place, the great city of Belgrade, by chance destroyed and bereft of people, and I rebuilt it and dedicated it to Our Lady, the Most Holy Mother of God”, wrote Serbian ruler Despot Stefan Lazarevic, poet and humanist. He erected a beautiful city with a fortifi ed castle, and two river ports.
Belgrade is the administrative and cultural capital of Serbia.
The city is situated where the Sava River fl ows into the mighty Danube, and where the cultivated Panonian Plain meets the hilly and mountainous Balkans.
Though a metropolis scared with history, it remains unquenchably optimistic. Belgrade is a hospitable and lively city. It is a wild, untamable city, to be loved rather than merely appreciated.
The best time for a visit is in spring. In May and June, the sweet smell of linden trees pervades many of its streets. A short walk to one of the riverbanks provides an escape from the city bustle, and offers a choice of numerous restaurants built on rafts.
Because all of this and much more, Belgrade is a city to enjoy, and feel surprisingly good in.
Belgrade
32 Danubian League against Thrombosis and Haemorrhagic Disorders
Meeting Venue
BEST WESTERN Hotel M
Bulevar oslobođenja 56a11000 Belgrade, SerbiaTel: + 381 11 30 90 505 Website: www.hotel-m.com
Meeting DateMay 14 – 16, 2009
LanguageThe offi cial language of the Meeting is English.
WebsiteThe offi cial website of the Meeting is www.DanubianLeagueBelgrade.com
BadgesAll participants will receive name badge at the registration desk. Badge should be visible all times at the Meeting venue.
Badges have been coded as folows:Orange ParticipantsBlue ExhibitorsYellow Organizators
ExhibitionA commercial exhibition of pharmaceutical items and technical equipment will be organized during the Meeting.
The exhibition is opened:
Thursday May 14 14:00 – 19:00Friday May 15 09:00 – 17:00Saturday May 16 09:00 – 15:00
On-site SecretariatThe Registration and Information Desk willoperate at the Meeting venue:
Thursday May 14 12:00 – 19:00Friday May 15 08:30 – 19:00Saturday May 16 08:30 – 15:30
Registration Fee on-site150 EUR (in RSD)
The on-site registration fee for participants covers:- Access to the Scientifi c Sessions and
Exhibition- Printed material of the Meeting- Certifi cate of Attendance- Opening Ceremony & Welcome Reception,
May 14, 2009- Lunch and Coffee Break, May 14 – 16, 2009
Technical Organizer & Offi cial Travel AgencyTP “Mladost turist” A.D.
Bulevar Oslobođenja 56a , 11000 Belgrade, SerbiaTel: + 381 11 3095 505, Fax: + 381 11 3095 506
E-mail: [email protected] Website: www.hotel-m.com
General Information
15th International Meeting, Belgrade 2009 33
Scientifi c Information
Oral Sessions Oral sessions include:Plenary Lectures – 30 minState of the Art – 20 minOral Presentations – 10 min
Slide preview room is available.
Please hand your presentation at least 2 hours before start of your session.
Poster SessionPosters should be mounted at the designated area in Room Forum according to the numbers given in the fi nal Programme.
Helmut Vinazzer AwardThe author of the best poster will be awarded at the Gala Dinner, May 15.
Abstract Book and Programme The Abstract Book and Programme will be included in the Meeting bags.
Certifi cate of AttendanceA Certifi cate of Attendance will be given to each registrated participant during the Meeting.
Social Events
Opening Ceremony Thursday, May 14, 200919:00-19:45Room Atrium
Welcome ReceptionThursday May 14, 200920:00 – 22:00Business Centre
Included in the registration fee.
Gala DinnerFriday, May 15, 200920:30-00:00Kalemegdanska terasa
Included in the registration fee for the fi rst 250 participants.
Visit to the Royal PalaceSunday, May 16, 200908:30-10.00
Visit organized forone hundred participants.
Spon
sorin
g an
d Ex
hibi
tion
36 Danubian League against Thrombosis and Haemorrhagic Disorders
THURSDAY, MAY 14 17:00-18:00 Bayer Health Care, Bayer Schering Pharma Recombinant FVIII and hemophilia A
Maria Elisa MancusoUsage of rFVIII in children in Italy
Nada Gvozdenovic-RasovicFirst experience with rFVIII in the treatment of patient with severe hemophilia A
Dusan AvramovicXarelto - the fi rst oral, direct Factor Xa inhibitor
18:00-19:00 Siemens Healthcare Diagnostics and Interlab exim
Christine Dahler- Challenges and benefi ts of D-dimer testing- The new INNOVANCE D-Dimer - State-of-the-art antithrombin testing
Richard Morales- The Next Generation of Hemostasis Analyzers, the CS-2000i
FRIDAY, MAY 1513:00-14:00 Novo Nordisk
Guenter Auerswald Prophylaxis in patients with inhibitors to haemophilia A
Ivo Elezovic Acquired haemophilia-are we aware enough?
17:15-17:30 Instrumentation Laboratory
Alberto StradaInnovation is here – IL proposal to modern coagulation lab
17:30-18:30 Baxter
SATURDAY, MAY 1613:00-14:00 Octapharma Human proteins for human patients
Erling NorrbyThe evolutionary chess game between viruses and man - Subcellular infection agents: viruses, prions and more
Andrea Neisser-SvaePathogen inactivaton - The defi nitive safeguard for plasma
Satellite Symposia